PASSAMONTI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 344
NA - Nord America 341
AS - Asia 81
OC - Oceania 19
SA - Sud America 7
AF - Africa 6
Totale 798
Nazione #
US - Stati Uniti d'America 329
IT - Italia 130
FR - Francia 67
GB - Regno Unito 50
JP - Giappone 24
AU - Australia 17
DE - Germania 15
CN - Cina 13
ES - Italia 12
HK - Hong Kong 12
IN - India 12
CA - Canada 11
NL - Olanda 9
CH - Svizzera 7
IE - Irlanda 7
CZ - Repubblica Ceca 6
HR - Croazia 6
AT - Austria 5
DK - Danimarca 5
CL - Cile 4
FI - Finlandia 4
VN - Vietnam 4
BE - Belgio 3
EG - Egitto 3
MK - Macedonia 3
PK - Pakistan 3
PL - Polonia 3
RO - Romania 3
SE - Svezia 3
BR - Brasile 2
GR - Grecia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
SG - Singapore 2
ZA - Sudafrica 2
CO - Colombia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
RU - Federazione Russa 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
Totale 798
Città #
Como 48
Ashburn 23
Fairfield 18
Houston 16
Seattle 16
Atlanta 14
Milan 14
Buffalo 13
London 13
Woodbridge 12
Sydney 10
Cambridge 8
Chicago 8
New York 8
Varese 8
Central 7
Dublin 7
Los Angeles 7
Rome 7
Cedar Knolls 6
Wilmington 6
Zurich 6
Chagrin Falls 5
Columbus 5
Council Bluffs 5
Madrid 5
Nashville 5
Paris 5
Tokyo 5
Zagreb 5
Bologna 4
Brookline 4
Brooklyn 4
Helsinki 4
Jamaica Plain 4
Okayama 4
Philadelphia 4
Portland 4
Rockville 4
Santa Cruz 4
Santiago 4
Shanghai 4
Shintomicho 4
Sioux Falls 4
Toronto 4
Amsterdam 3
Avonsleigh 3
Bengaluru 3
Boston 3
Brisbane 3
Cardiff 3
Dallas 3
Florence 3
Hong Kong 3
Modena 3
Padova 3
Tampa 3
Albano Laziale 2
Angers 2
Ann Arbor 2
Assiut 2
Austin 2
Bethesda 2
Binondo 2
Boardman 2
Cerveteri 2
Chiari 2
Colchester 2
Crugers 2
Deiva Marina 2
Dong Ket 2
Ellicott City 2
Flushing 2
Fontebuona 2
Frankfurt am Main 2
Fremont 2
Genoa 2
Grand Rapids 2
Herndon 2
Hightstown 2
Houten 2
Hove 2
Kirkland 2
Komatsubaradori 2
Lahore 2
Limpsfield 2
Lyon 2
Madison 2
Majadahonda 2
Mostoles 2
Muizenberg 2
Mysore 2
Mérignac 2
Nottingham 2
Paullo 2
Pescara 2
Phoenix 2
Port Coquitlam 2
Queens 2
Risskov 2
Totale 497
Nome #
DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status., file e2188be6-31a7-4564-e053-6605fe0a49d6 226
Myelofibrotic transformation in essentialthrombocythemia. Author reply, file e2188be6-a1a1-4564-e053-6605fe0a49d6 119
Defining disease modification in myelofibrosis in the era of targeted therapy, file 9d65a6b4-7517-427f-bf17-fa3c7bbfde74 62
A gain-of-function mutation of JAK2 in myeloproliferative disorders, file e2188be6-3d7a-4564-e053-6605fe0a49d6 62
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study, file f58141d3-e6f8-44a5-80e9-ebd7dd607e93 48
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts, file b6a3d92c-82ad-433e-8b09-9a57d413de39 33
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus, file 295f6438-2516-48d8-8317-ef674ba2faa1 22
Fedratinib improves myelofibrosis-related symptoms and health-related quality of life in patients with myelofibrosis previously treated with ruxolitinib: patient-reported outcomes from the phase II JAKARTA2 trial, file 6764ee9a-3870-4f8e-b1c9-ad2ed26e089b 22
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients, file fb792f4c-9b77-477d-b0d3-ff59cb96b8aa 22
Classification of myeloproliferative neoplasms and prognostic factors, file e2188be6-3948-4564-e053-6605fe0a49d6 21
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis, file c5f13a48-cf42-460b-b61c-7da53d3b94d3 19
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation, file e2188be8-225b-4564-e053-6605fe0a49d6 18
Philadelphia-negative chronic myeloproliferative neoplasms during the covid-19 pandemic: challenges and future scenarios, file a5402e0c-e657-4cae-8bb7-3dea8d9e2bc6 17
EPICOVIDEHA: A ready to use platform for epidemiological studies in hematological patients with COVID-19, file c229cae2-a795-4958-9f0d-fcc922c4e87d 16
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA, file 6863e1be-8f96-4fa5-88a4-a4b1137980a2 12
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia., file e2188be6-35fc-4564-e053-6605fe0a49d6 12
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP, file eac0fbdc-f237-4f94-9c61-6789d12cc76f 11
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study, file 8fc068df-881d-4e5f-85eb-082021603767 10
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study., file e2188be6-3db2-4564-e053-6605fe0a49d6 10
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project, file 72d48fd0-80c5-4a9b-b2e8-c8cb08f348b8 7
Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis, file e2188be6-35c2-4564-e053-6605fe0a49d6 7
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera, file e2188be6-3b52-4564-e053-6605fe0a49d6 7
The EHA research roadmap: malignant myeloid diseases, file 52219f1d-7fee-4797-8122-d0f6ed7c61de 6
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion, file e2188be6-c7b4-4564-e053-6605fe0a49d6 6
A prognostic model to predict survival in 867 WHO-defined essential thrombocythemia at diagnosis: a study by the IWG-MRT., file e2188be6-31a8-4564-e053-6605fe0a49d6 3
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub, file e2188be7-1399-4564-e053-6605fe0a49d6 3
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib, file 84885a46-2b24-42f6-be11-92e23d038f6a 1
Mutations and thrombosis in essential thrombocythemia: Prognostic interaction with age and thrombosis history, file e2188be6-2e4f-4564-e053-6605fe0a49d6 1
Totale 803
Categoria #
all - tutte 3.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 9 6
2019/202038 4 2 3 8 3 4 3 3 3 2 2 1
2020/202129 2 0 3 1 2 0 3 0 9 6 2 1
2021/202237 3 4 0 0 2 1 1 0 12 4 6 4
2022/2023541 36 59 66 53 40 58 74 46 36 37 16 20
2023/2024132 7 9 13 7 27 8 26 25 2 8 0 0
Totale 803